UK Sees Tripling of ADHD Medication Use Over 13-Year Period, Study Reveals
A recent study has found that the use of Attention Deficit Hyperactivity Disorder (ADHD) medications in the UK has more than tripled over the past decade, with a significant increase observed among women. The research, published in the Lancet Regional Health – Europe journal, used electronic health records from five European countries to estimate the prevalence of ADHD medication use among adults and children aged three and above.
The study revealed that the proportion of people in the UK on ADHD medication increased by over 300% between 2010 and 2023. In women aged 25 and over, the increase was a staggering 20-fold, while men saw a 15-fold rise in medication use. The researchers noted that despite higher rates of medication use among males, the sex gap in treatment narrowed significantly with increasing age.
The most commonly used ADHD medication in the UK was methylphenidate, which accounted for over 70% of all prescriptions. However, continuation rates for these medications were relatively low, varying between countries. The study's findings have significant implications for healthcare planning and highlight the need for systems to anticipate demand and reduce the risk of future medication shortages.
The researchers also noted that the growing recognition of ADHD as a lifelong condition may be contributing to increased treatment rates. However, they cautioned that not everyone with ADHD requires medication, suggesting that a substantial proportion may not be doing so. The study's lead author, Xintong Li, stated that while there is increasing awareness and diagnosis of adult ADHD, there are also concerns about long-term treatment patterns and care needs.
The study's findings come as the UK National Health Service (NHS) struggles with overspending on ADHD services, with an estimated £164m annual deficit. Private assessments for ADHD have also seen a significant increase, leading to calls for better regulation of these services. With demand for ADHD medications expected to more than double existing NHS budgets, the study highlights the need for healthcare systems to plan for rising demand and mitigate potential shortages.
A recent study has found that the use of Attention Deficit Hyperactivity Disorder (ADHD) medications in the UK has more than tripled over the past decade, with a significant increase observed among women. The research, published in the Lancet Regional Health – Europe journal, used electronic health records from five European countries to estimate the prevalence of ADHD medication use among adults and children aged three and above.
The study revealed that the proportion of people in the UK on ADHD medication increased by over 300% between 2010 and 2023. In women aged 25 and over, the increase was a staggering 20-fold, while men saw a 15-fold rise in medication use. The researchers noted that despite higher rates of medication use among males, the sex gap in treatment narrowed significantly with increasing age.
The most commonly used ADHD medication in the UK was methylphenidate, which accounted for over 70% of all prescriptions. However, continuation rates for these medications were relatively low, varying between countries. The study's findings have significant implications for healthcare planning and highlight the need for systems to anticipate demand and reduce the risk of future medication shortages.
The researchers also noted that the growing recognition of ADHD as a lifelong condition may be contributing to increased treatment rates. However, they cautioned that not everyone with ADHD requires medication, suggesting that a substantial proportion may not be doing so. The study's lead author, Xintong Li, stated that while there is increasing awareness and diagnosis of adult ADHD, there are also concerns about long-term treatment patterns and care needs.
The study's findings come as the UK National Health Service (NHS) struggles with overspending on ADHD services, with an estimated £164m annual deficit. Private assessments for ADHD have also seen a significant increase, leading to calls for better regulation of these services. With demand for ADHD medications expected to more than double existing NHS budgets, the study highlights the need for healthcare systems to plan for rising demand and mitigate potential shortages.
I'm low-key surprised this hasn't happened sooner - our society is already moving so fast! 
We should be used to seeing people popping pills left and right by now. 
And it's not like the NHS isn't doing enough - they're just trying to keep up with demand, which is kinda fair I guess. 
My point is, why aren't we talking about natural treatments for ADHD instead of shoving meds down people's throats? 
It seems like everyone's jumping on the medication bandwagon without considering the long-term effects... 
- tripling of ADHD medication use in just 13 years is crazy! And it's not like people are getting older, but still, we gotta figure out why this is happening. I mean, I've got friends who are super focused on their work or whatever, but they're not bouncing off the walls like some people I know 
. It's also worrying that private assessments for ADHD have skyrocketed, and now NHS is struggling to keep up... we need better systems in place 
. Can't just rely on meds, though - maybe more focus on education, therapy, or something? 
. It's not surprising that ADH meds are up in the UK but it feels like we're just treating the symptoms rather than addressing the root causes 
. I mean, £164m deficit on NHS ADHD services? That's a lot of money 
. We need to think outside the box here 
and explore more holistic approaches that don't rely so heavily on medication 
. And what about those who can't access meds through the NHS or are having to shell out privately? It's all getting really complicated 
& thats not all wimnz r more than 20 times more likely 2 b prescribed these meds @ age 25+ whil men are only 15x more 
. I know a lot of people who've been diagnosed and they swear by their meds 
. But at the same time, I get that not everyone needs 'em, you know? It's like, can't we just find ways to stay focused without relying on meds all the time? 
this is crazy! tripled use over 13 years? that's insane 
I hope they have enough meds to go around 
I'm glad we're getting more aware of ADHD but it's also kinda scary how high the rates are 
anyhoo, NHS gotta step up their game and make sure they're prepared for this rise in demand 
and I'm over here thinking "is this a sign we've finally cracked the code on attention spans? 
The NHS is already struggling with overspending on ADHD services, so this isn't exactly the kind of 'breakthrough' we need... more like a 'costly fix'. 
. I mean, 300% increase is wild - maybe we should just consider it a rite of passage for millennials now? 
. We don't want people struggling to get the meds they need because there aren't enough 
. The NHS has a big budget for ADHD services now and all... hope they can keep up